The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems

Abstract

The dual hypocretin receptor (HcrtR) antagonist almorexant (ALM) may promote sleep through selective disfacilitation of wakepromoting systems, whereas benzodiazepine receptor agonists (BzRAs) such as zolpidem (ZOL) induce sleep through general inhibition of neural activity. Previous studies have indicated that HcrtR antagonists cause less-functional impairment than BzRAs. To gain insight into the mechanisms underlying these differential profiles, we compared the effects of ALM and ZOL on functional activation of wake-promoting systems at doses equipotent for sleep induction. Sprague-Dawley rats, implanted for EEG/EMG recording, were orally administered vehicle (VEH), 100 mg/kg ALM, or 100 mg/kg ZOL during their active phase and either left undisturbed or kept awake for 90 min after which their brains were collected. ZOL-treated rats required more stimulation to maintain wakefulness than VEH-or ALM-treated rats. We measured Fos co-expression with markers for wake-promoting cell groups in the lateral hypothalamus (Hcrt), tuberomammillary nuclei (histamine; HA), basal forebrain (acetylcholine; ACh), dorsal raphe (serotonin; 5HT), and singly labeled Fos + cells in the locus coeruleus (LC). Following SD, Fos co-expression in Hcrt, HA, and ACh neurons (but not in 5HT neurons) was consistently elevated in VEH-and ALMtreated rats, whereas Fos expression in these neuronal groups was unaffected by SD in ZOL-treated rats. Surprisingly, Fos expression in the LC was elevated in ZOL-but not in VEH-or ALM-treated SD animals. These results indicate that Hcrt signaling is unnecessary for the activation of Hcrt, HA, or ACh wake-active neurons, which may underlie the milder cognitive impairment produced by HcrtR antagonists compared to ZOL.

Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia

“…These data support the hypothesis that daridorexant selectively blocks orexin-induced excitation of wake-promoting regions but does not block the possible activation of these regions by other neurotransmitters released when one needs to wake up (Parks et al 2016 ). Positive GABA-A receptor modulators, in contrast, induce sleep through widespread inhibition of the CNS, and thus, the threshold for arousal might be increased.…”

Seasonal decrease in thermogenesis and increase in vasoconstriction explain seasonal response to N6‐cyclohexyladenosine‐induced hibernation in the Arctic ground squirrel (Urocitellus parryii)

“…S1f). The histamine‐ir pattern in AGS is identical to the pattern seen in rats stained with the same rabbit anti‐histamine () after 4% 1‐ethyl‐3‐[3‐dimethylaminopropyl] carbodiimide perfusion (Ellender et al, ; Noseda et al, ), and to the histaminergic neurons at bregma −3.80 identified by adenosine deaminase‐ir (Parks et al, ). TH‐ir was detected in the catecholaminergic neurons in the locus coeruleus (LC) (box1, Fig.…”

The natural Disc1-deletion present in several inbred mouse strains does not affect sleep

“…Sleep scoring and analysis was done as reported before 38 , 46 , 47 . EEG, EMG, and signal strength (as proxy for locomotor activity) were recorded via telemetry using DQ ART software (Data Sciences International).…”